Last reviewed · How we verify

Spinal analgesia with bupivacaine

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · Phase 1 active Small molecule

Spinal analgesia with bupivacaine is a Small molecule drug developed by Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia. It is currently in Phase 1 development.

At a glance

Generic nameSpinal analgesia with bupivacaine
SponsorFundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Spinal analgesia with bupivacaine

What is Spinal analgesia with bupivacaine?

Spinal analgesia with bupivacaine is a Small molecule drug developed by Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia.

Who makes Spinal analgesia with bupivacaine?

Spinal analgesia with bupivacaine is developed by Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia (see full Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia pipeline at /company/fundacion-para-la-formacion-e-investigacion-sanitarias-de-la-region-de-murcia).

What development phase is Spinal analgesia with bupivacaine in?

Spinal analgesia with bupivacaine is in Phase 1.

Related